Patent · US Active

Cis-imidazolines

US7705007B2 · kind B2 · utility

24Cited by
2References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 17, 2007
Grant dateApr 27, 2010
Priority date
Expiry dateMay 2, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

There are provided compounds of the formula Iwherein R, V1, V2 and Ring A are described herein. The compounds exhibit anticancer activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.